Globus Medical, Inc.

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A has 1.08B shares outstanding.

As of June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A maintains a current ratio of 4.62, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A posted a return on equity (ROE) of 11.81, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.16 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 10.25, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.52, useful for judging operating efficiency across full business cycles. The company generates approximately 2.79M in revenue per employee across its workforce of 5,825.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.25 indicates how many times Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A recorded 644.51M in income tax expense. That works out to an effective tax rate of 18.89, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.41B, leaving 2.77B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on September 14, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A's stock has gained approximately 22.32% over the past 52 weeks.

Over the twelve months ended June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A generated 16.26B in revenue and converted that into 2.77B in net income, yielding earnings per share of 2.52. EBITDA reached 4.75B, while operating income came in at 3.48B.

As of June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A holds 3.08B in cash and equivalents against 574.75M in total debt, resulting in a net debt position of -2.62B. Total book value stands at 24.65B, with working capital of 8.97B providing operational flexibility.

Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A produced 4.71B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -824.68M in capital expenditures, free cash flow totaled 3.88B - equivalent to 3.59 per share.

Over the twelve months ended June 30, 2026, Globus Medical Inc Shs A Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh A posted a gross margin of 68.55, reflecting its pricing power and cost economics. The operating margin of 21.42 and net profit margin of 17.03 provide insight into operational efficiency.